• Tue, November 22, 2016

by: WOPRAI

SHOR SqueezeTrigger Price is $6.93. There is $6,733,300 That Short Sellers Still Need To Cover.

by: WOPRAI

CFBK SqueezeTrigger Price is $1.50. There is $32,550 That Short Sellers Still Need To Cover.

by: WOPRAI

WILC SqueezeTrigger Price is $6.07. There is $34,082 That Short Sellers Still Need To Cover.

by: WOPRAI

PNTR SqueezeTrigger Price is $7.68. There is $92,225 That Short Sellers Still Need To Cover.

by: WOPRAI

MIK SqueezeTrigger Price is $24.41. There is $144,756,552 That Short Sellers Still Need To Cover.

by: WOPRAI

ARTX SqueezeTrigger Price is $3.45. There is $960,838 That Short Sellers Still Need To Cover.

by: WOPRAI

MEDICAL MARIJUANA I (OTC:MJNA), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Re

by: WOPRAI

iPath Dow Jones-AIG Natural Gas Total Return Sub-IndexSM ETN (NYSE:GAZ), Down After BUYINS.NET Report Predicted Stock Would Go

by: WOPRAI

Terra Tech Corp (OTC:TRTC), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

Paypal Inc. (NASDAQ:PYPL), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

Mast Therapeutics Inc. (NYSE:MSTX), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Re

by: WOPRAI

Anavex Life Sciences Corp (NASDAQ:AVXL), Up By $0.64 (18.94%) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, Octob

by: WOPRAI

ProShares Indices (NYSE:UMDD), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

ImmunoCellular Therapeutics Ltd (NYSE:IMUC), Up By $2.05 (164.42%) After BUYINS.NET SqueezeTrigger Report Released on Monday, N

by: WOPRAI

FstTr ET AlDex Shs Large Cap Growth AlphaDEX Fund (NASDAQ:FTC), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To C

by: WOPRAI

Teck Resources Limited (NYSE:TCK), Up By $1.55 (6.67%) After BUYINS.NET SqueezeTrigger Report Released on Monday, November 21st

by: WOPRAI

Cerecor (NASDAQ:CERC), Up By $1.63 (43.31%) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, November 1st 2016 at a

by: WOPRAI

Vivus, Inc. (NASDAQ:VVUS) Up By 29.81% ($0.31) From $1.040 After BUYINS.NET Report Predicted Strength After Earnings

by: WOPRAI

California Water Service Group (NYSE:CWT), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In

by: WOPRAI

COLL SqueezeTrigger Price is $17.05. There is $47,993,847 That Short Sellers Still Need To Cover.

by: WOPRAI

MYE SqueezeTrigger Price is $14.51. There is $3,325,550 That Short Sellers Still Need To Cover.

by: WOPRAI

MGP SqueezeTrigger Price is $24.44. There is $55,424,440 That Short Sellers Still Need To Cover.

by: WOPRAI

KFS, BSQR, CNBKA, CHSP, Expected to Trade Higher After Bullish Insider Trading

by: WOPRAI

CWCO, MTSI, PB, SALE, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

CSII, STAR, QCOM, PLT, ETM, DUK, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

BOM, JVA, ROSG, CEL, EFC Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

LL Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

BSFT, VPG, VTWO, PRMW, INXN, FIW Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

CWB, DISCK, STWD, MG, PALL, AOSL Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

ROCK, NUVA, ABC, TPX, SGMO, ACTG Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

Jay Olson Initiated (TXMD) at Buy and Held Target at $12 on, Nov 22nd, 2016

by: WOPRAI

Akshay Jagdale Maintained (TSN) at Strong Buy with Decreased Target to $75 on, Nov 22nd, 2016

by: WOPRAI

Robert Moskow Maintained (TSN) at Hold with Decreased Target to $65 on, Nov 22nd, 2016

by: WOPRAI

David Scharf Maintained (SYF) at Buy with Increased Target to $37 on, Nov 22nd, 2016

by: WOPRAI

Sheryl Skolnick Downgraded (THC) to Sell on, Nov 22nd, 2016

by: WOPRAI

Michael Derchin Downgraded (UAL) to Hold and Increased Target to $76 on, Nov 22nd, 2016

by: WOPRAI

Stephen Laws Initiated (AJX) at Buy and Held Target at $16 on, Nov 22nd, 2016

by: WOPRAI

Mauricio Fernandes Upgraded (AMX) to Strong Buy and Increased Target to $14 on, Nov 22nd, 2016

by: WOPRAI

Richard Valera Initiated (ANSS) at Hold on, Nov 22nd, 2016

by: WOPRAI

David Manthey Maintained (BECN) at Buy with Decreased Target to $56 on, Nov 22nd, 2016

by: WOPRAI

Vishal Shah Initiated (AYI) at Strong Buy and Held Target at $300 on, Nov 22nd, 2016

by: WOPRAI

James Naklicki Initiated (AXS) at Strong Sell on, Nov 22nd, 2016

by: WOPRAI

William Katz Downgraded (AB) to Hold on, Nov 22nd, 2016

by: WOPRAI

Julien Dumoulin-Smith Downgraded (AES) to Sell on, Nov 22nd, 2016

  • Wed, November 23, 2016

by: WOPRAI

Vivek Arya Upgraded (ADI) to Strong Buy and Held Target at $85 on, Nov 23rd, 2016

by: WOPRAI

Ross Seymore Maintained (ADI) at Hold with Increased Target to $70 on, Nov 23rd, 2016

by: WOPRAI

Karl Keirstead Maintained (VEEV) at Hold with Increased Target to $44 on, Nov 23rd, 2016

by: WOPRAI

Eric Beder Downgraded (URBN) to Hold on, Nov 23rd, 2016

Jay Olson Initiated (TXMD) at Buy and Held Target at $12 on, Nov 22nd, 2016

Jay Olson of Oppenheimer, Initiated "TherapeuticsMD, Inc." (TXMD) at Buy and Held Target at $12 on, Nov 22nd, 2016.

Jay, nor any peers, have made any analyst calls on TXMD in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍